References
- Kim YK, Kim SH, Tak YJ, Jee YK, Lee BJ, Kim SH, Park HW, et al. High prevalence of current asthma and active smoking effect among the elderly. Clin Exp Allergy 2002;32:1706–1712.
- Song WJ, Chang YS, Lim MK, Yun EH, Kim SH, Kang HR, Park HW, et al. Staphylococcal enterotoxin sensitization in a community-based population: a potential role in adult-onset asthma. Clin Exp Allergy 2014;44:553–562.
- Centers for Disease Control and Prevention. Asthma Surveillance Data. Available from: http://www.cdc.gov/asthma/asthmadata.htm [last accessed 20 Nov 2014].
- World Health Organization. Available from: http://www.who.int/respiratory/asthma/en [last accessed 20 Nov 2014].
- Ihre E, Zetterstrom O, Ihre E, Hammarberg B. Voice problems as side effects of inhaled corticosteroids patients-a prevalence study. J Voice 2004;18:403–414.
- Merrill RM, Anderson AE, Sloan A. Quality of life indicators according to voice disorders and voice-related conditions. Laryngoscope 2011;121:2004–2010.
- Asnaashari AM, Rezaei S, Babaeian M, Taiarani M, Shakeri MT, Fatemi SS, Darban AA. The effect of asthma on phonation: a controlled study of 34 patients. Ear Nose Throat J 2012;91:168–171.
- Hackenberg S, Hacki T, Hagen R, Kleinsasser NH. [Voice disorders in asthma]. Laryngorhinootologie 2010;89:460–464.
- Dogan M, Eryuksel E, Kocak I, Celikel T, Sehitoglu MA. Subjective and objective evaluation of voice quality in patients with asthma. J Voice 2007;21:224–230.
- Baker BM, Baker CD, Le HT. Vocal quality, articulation and audiological characteristics of children and young adults with diagnosed allergies. Ann Otol Rhinol Laryngol 1982;91:277–280.
- Ozbilen Acar G, Uzun Adatepe N, Kaytaz A, Edizer DT, Gemicioglu B, Yagiz C, Dirican A. Evaluation of laryngeal findings in users of inhaled steroids. Eur Arch Otorhinolaryngol 2010;267:917–923.
- Williamson IJ, Matusiewicz SP, Brown PH, Greening AP, Crompton GK. Frequency of voice problems and cough in patients using pressurized aerosol inhaled steroid preparations. Eur Respir J 1995;8:590–592.
- Carlsen KH. Inhaled steroids and local side-effects. Allergy 2001;56:925–927.
- Williams AJ, Baghat MS, Stableforth DE, Cayton RM, Shenoi PM, Skinner C. Dysphonia caused by inhaled steroids: recognition of a characteristic laryngeal abnormality. Thorax 1983;38:813–821.
- DelGaudio JM. Steroid inhaler laryngitis: dysphonia caused by inhaled fluticasone therapy. Arch Otolaryngol Head Neck Surg 2002;128:677–681.
- Crompton GK, Sanderson R, Dewar MH, Matusiewicz SP, Ning AC, Jamieson AH, McLean A, et al. Comparison of Pulmicort pMDI plus Nebuhaler and Pulmicort Turbuhaler in asthmatic patients with dysphonia. Respir Med 2000;94:448–453.
- Grant D. A caution in the use of laryngeal sprays. 1898. J Laryngol Otol 1998;112:506.
- Phillips PS, Hirani SP, Epstein R. Peak flow and voice pathology. J Voice 2009;23:521–528.
- Cohen SM, Kim J, Roy N, Asche C, Courey M. Prevalence and causes of dysphonia in a large treatment-seeking population. Laryngoscope 2012;122:343–348.
- Nerriere E, Vercambre MN, Gilbert F, Kovess-Masféty V. Voice disorders and mental health in teachers: a cross-sectional nationwide study. BMC Public Health 2009;9:370.
- Hocevar-Boltezar I. Prevalence and risk factors for voice problems in priests. Wien Klin Wochenschr 2009;121:276–281.